Chimerix to stop participation in clinical studies of Ebola drug
January 30, 2015 at 19:01 PM EST
Jan 30 (Reuters) - Drug developer Chimerix Inc said it would stop participation in clinical studies of its Ebola drug, brincidofovir, citing a significant decrease in the number new cases for the virus in Liberia.
